122 related articles for article (PubMed ID: 35149083)
21. MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma.
Komoll RM; Hu Q; Olarewaju O; von Döhlen L; Yuan Q; Xie Y; Tsay HC; Daon J; Qin R; Manns MP; Sharma AD; Goga A; Ott M; Balakrishnan A
J Hepatol; 2021 Jan; 74(1):122-134. PubMed ID: 32738449
[TBL] [Abstract][Full Text] [Related]
22. Disordered farnesoid X receptor signaling is associated with liver carcinogenesis in Abcb11-deficient mice.
Wang L; Luo Q; Zeng S; Lou Y; Li X; Hu M; Lu L; Liu Z
J Pathol; 2021 Dec; 255(4):412-424. PubMed ID: 34410012
[TBL] [Abstract][Full Text] [Related]
23. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
[TBL] [Abstract][Full Text] [Related]
24. Oncogene-dependent function of BRG1 in hepatocarcinogenesis.
Wang P; Song X; Cao D; Cui K; Wang J; Utpatel K; Shang R; Wang H; Che L; Evert M; Zhao K; Calvisi DF; Chen X
Cell Death Dis; 2020 Feb; 11(2):91. PubMed ID: 32019910
[TBL] [Abstract][Full Text] [Related]
25. TNF-α/NF-κB signaling epigenetically represses PSD4 transcription to promote alcohol-related hepatocellular carcinoma progression.
Shi J; Song S; Li S; Zhang K; Lan Y; Li Y
Cancer Med; 2021 May; 10(10):3346-3357. PubMed ID: 33932127
[TBL] [Abstract][Full Text] [Related]
26. Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls.
Zhang X; Yang Z; Shi Z; Zhu Z; Li C; Du Z; Zhang Y; Wang Z; Jiao Z; Tian X; Zhang J; Zhai W; Kan Q
J Steroid Biochem Mol Biol; 2021 Jan; 205():105775. PubMed ID: 33130021
[TBL] [Abstract][Full Text] [Related]
27. Elk1 and AP-1 sites in the TBP promoter mediate alcohol-induced deregulation of Pol III-dependent genes.
Zhong Q; Shi G; Zhang Y; Levy D; Zhong S
Gene; 2013 Aug; 526(1):54-60. PubMed ID: 23454483
[TBL] [Abstract][Full Text] [Related]
28. Aryl hydrocarbon receptor (AhR) mediated short-term effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on bile acid homeostasis in mice.
Csanaky IL; Lickteig AJ; Klaassen CD
Toxicol Appl Pharmacol; 2018 Mar; 343():48-61. PubMed ID: 29452137
[TBL] [Abstract][Full Text] [Related]
29. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
30. A Dual Coverage Monitoring of the Bile Acids Profile in the Liver-Gut Axis throughout the Whole Inflammation-Cancer Transformation Progressive: Reveal Hepatocellular Carcinoma Pathogenesis.
Xing L; Zhang Y; Li S; Tong M; Bi K; Zhang Q; Li Q
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901689
[TBL] [Abstract][Full Text] [Related]
31. Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis.
Xie G; Wang X; Huang F; Zhao A; Chen W; Yan J; Zhang Y; Lei S; Ge K; Zheng X; Liu J; Su M; Liu P; Jia W
Int J Cancer; 2016 Oct; 139(8):1764-75. PubMed ID: 27273788
[TBL] [Abstract][Full Text] [Related]
32. Individual bile acids have differential effects on bile acid signaling in mice.
Song P; Rockwell CE; Cui JY; Klaassen CD
Toxicol Appl Pharmacol; 2015 Feb; 283(1):57-64. PubMed ID: 25582706
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome.
Herceg Z; Paliwal A
Mutat Res; 2011; 727(3):55-61. PubMed ID: 21514401
[TBL] [Abstract][Full Text] [Related]
34. Targeting p300/CBP Attenuates Hepatocellular Carcinoma Progression through Epigenetic Regulation of Metabolism.
Cai LY; Chen SJ; Xiao SH; Sun QJ; Ding CH; Zheng BN; Zhu XY; Liu SQ; Yang F; Yang YX; Zhou B; Luo C; Zhang X; Xie WF
Cancer Res; 2021 Feb; 81(4):860-872. PubMed ID: 33361394
[TBL] [Abstract][Full Text] [Related]
35. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
[TBL] [Abstract][Full Text] [Related]
36. Dysregulation of bile acid homeostasis in parenteral nutrition mouse model.
Zhan L; Yang I; Kong B; Shen J; Gorczyca L; Memon N; Buckley BT; Guo GL
Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(2):G93-G102. PubMed ID: 26564717
[TBL] [Abstract][Full Text] [Related]
37. Deregulated bile acids may drive hepatocellular carcinoma metastasis by inducing an immunosuppressive microenvironment.
Xia JK; Tang N; Wu XY; Ren HZ
Front Oncol; 2022; 12():1033145. PubMed ID: 36338764
[TBL] [Abstract][Full Text] [Related]
38. Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids.
Yang T; Shu T; Liu G; Mei H; Zhu X; Huang X; Zhang L; Jiang Z
J Steroid Biochem Mol Biol; 2017 Sep; 172():69-78. PubMed ID: 28583875
[TBL] [Abstract][Full Text] [Related]
39. Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target.
Ningarhari M; Caruso S; Hirsch TZ; Bayard Q; Franconi A; Védie AL; Noblet B; Blanc JF; Amaddeo G; Ganne N; Ziol M; Paradis V; Guettier C; Calderaro J; Morcrette G; Kim Y; MacLeod AR; Nault JC; Rebouissou S; Zucman-Rossi J
J Hepatol; 2021 May; 74(5):1155-1166. PubMed ID: 33338512
[TBL] [Abstract][Full Text] [Related]
40. Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency.
Knisely AS; Strautnieks SS; Meier Y; Stieger B; Byrne JA; Portmann BC; Bull LN; Pawlikowska L; Bilezikçi B; Ozçay F; László A; Tiszlavicz L; Moore L; Raftos J; Arnell H; Fischler B; Németh A; Papadogiannakis N; Cielecka-Kuszyk J; Jankowska I; Pawłowska J; Melín-Aldana H; Emerick KM; Whitington PF; Mieli-Vergani G; Thompson RJ
Hepatology; 2006 Aug; 44(2):478-86. PubMed ID: 16871584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
